A Phase I Study of an Oral Simulated FOLFOX with High Dose Capecitabine

BACKGROUND: A phase I study of high-dose capecitabine given over 2 days, along with oxaliplatin, bolus 5FU and leucovorin (LV), was designed to simulate FOLFOX6 without the need for infusional 5FU. METHODS: Schedule A included oxaliplatin 100 mg/m(2), 5FU 400 mg/m(2), and LV 20 mg/m(2) (all given IV...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mulkerin, D., LoConte, N.K., Holen, K.D., Thomas, J.P., Alberti, D., Marnocha, R., Kolesar, J., Eickhoff, J., Oliver, K., Feierabend, C., Wilding, G.
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2899673/
https://ncbi.nlm.nih.gov/pubmed/19129971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-008-9210-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires